Harness Dickey
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
    • Professional Staff
    • Attorneys
    • Life at Harness Dickey
    • Community
    • Global IP Management & Tracking
    • Global Network
    • Diversity
    • Offices
    • Careers
  • IP Atlas
    • Legal Notice
    • Practice Areas
    • IP Atlas
    • Post Grant Review
    • Inter Partes Review
    • Current Openings
    • Welcome to the Harness Dickey Staff Page
    • Professional Staff
    • Attorneys
    • Life at Harness Dickey
    • Community
    • Global IP Management & Tracking
    • Global Network
    • Diversity
    • Global Network
    • Foreign Clients Doing Business in the U.S.
    • Domestic Clients Doing Business Abroad
    • Trade Secrets & Unfair Competition
    • Appellate
    • Inter Partes Review, Post-Grant Review & Other PTO Proceedings
    • Domain Name Disputes
    • Trademark Litigation
    • Copyright Litigation
    • Patent Litigation
    • Cross Border Transactions
    • Licensing & Joint Ventures
    • Due Diligence
    • FTO Opinions
    • Patent Prosecution
    • Trademark & Domain Name Protection
    • Maximizing Trademark Rights
    • Enforcement
    • TTAB Proceedings
    • Global Trademark Strategy
    • Anticounterfeiting
    • Trademark Selection, Prosecution & Registration
    • Customs & Border Protection
    • Copyright Registration & Counseling
    • Authors
    • Page Not Found
    • Privacy Statement
    • Industries
    • Case Studies
    • News & Awards
    • People
    • Offices
    • Careers
    • About Us
    • Blog
    • Home
  • Contact Us
  • Client Login

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Our business model is to cultivate lawyers who know all there is to know about intellectual property, whether it be special requirements under the America Invents Act (AIA), patenting chemical compositions and pharmaceuticals, current developments in software patenting, or combating “bad patents” in federal court litigation.  Lawyers from our various practice groups enjoy sharing their views in our blogs. Please join our audience and help us enrich the discussion. We welcome your participation and insight.

  • BioPharma
    • All Categories
    • BioPharma
    • Chemistry & Nanotechnology
    • Featured
    • Harnessing the Lessons of IP
    • IP Management
    • IPR-PGR
    • Licensing
    • Litigation
    • Patent Prosecution
    • Trademarks
  • All Years
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
  • Authors
    • John H. Ambrose, Jr.John H. Ambrose, Jr. 2
    • Tyson B. BensonTyson B. Benson 2
    • Jewell N. BriggsJewell N. Briggs 3
    • Elizabeth K. BrockElizabeth K. Brock 7
    • Matthew L. CutlerMatthew L. Cutler 183
    • Donald J. DaleyDonald J. Daley 1
    • Darin W. DeaverDarin W. Deaver 1
    • Gregory S. DeLassusGregory S. DeLassus 43
    • Nicholas S. DrysdaleNicholas S. Drysdale 3
    • Monte L. FalcoffMonte L. Falcoff 1
    • Glenn E. ForbisGlenn E. Forbis 10
    • Mark A. Frentrup, Ph.D.Mark A. Frentrup, Ph.D. 3
    • Michael GambleMichael Gamble 1
    • Jason A. HeistJason A. Heist 1
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 1
    • Damian H. Kotsis, Ph.D.Damian H. Kotsis, Ph.D. 2
    • Kisuk LeeKisuk Lee 1
    • Robert J. LenihanRobert J. Lenihan 1
    • Joshua A. PartingtonJoshua A. Partington 2
    • Leanne M. RakersLeanne M. Rakers 14
    • Douglas A. RobinsonDouglas A. Robinson 11
    • Joel R. SamuelsJoel R. Samuels 3
    • Neal D. SanbornNeal D. Sanborn 3
    • Jeffrey L. SnyderJeffrey L. Snyder 1
    • Gregory A. StobbsGregory A. Stobbs 9
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 2
    • Michael VarcoMichael Varco 2
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 1
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 278
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 7
    • Paul E. Zarek, Ph.D.Paul E. Zarek, Ph.D. 2

  • August 17, 2017

    You Can Ignore Claim Language As Long As it is Before the Colon

    More

  • August 15, 2017

    No man is an island, but Taiwan is, and so are Cabo Verde, Fiji, the Maldives, the Solomon Islands and Vanuatu

    More

  • August 15, 2017

    Clarity in §101: Half of the Judges Considering the Question Find Plaintiff’s Computer Memory System to be Patentable Subject Matter

    More

  • August 11, 2017

    Check Each Link in the Chain of Title; The Time to Find Out Your Assignor Does Not Exist is Before you Sue

    More

  • August 10, 2017

    Whether You Need to Show Standing Depends on Where You Are Standing

    More

  • August 10, 2017

    When is July 4 this year? When is North Carolina’s FIRST TUESDAY Lottery? and Descriptiveness

    More

June 13, 2017

You Don’t Have to Dance the Patent Dance (Except Maybe in California)

May 25, 2017

BioPharma Patents Quick Tips & News – November 2014 – Throwback Edition

March 13, 2017

BioPharma Patents Quick Tips & News – July/August 2014 – Throwback Edition

February 27, 2017

SCOTUS to Weigh In on Two Biosimilar Provisions of the BPCIA in 2017

February 2, 2017

Harnessing the Innovation of BioPharma

January 12, 2017

BioPharma Patents Quick Tips & News – May/June 2014 – Throwback Edition

November 14, 2016

BioPharma Patents Quick Tips & News – January/February 2014 – Throwback Edition

October 24, 2016

BioPharma Patents Quick Tips & News – October 2016

September 8, 2016

BioPharma Patents Quick Tips & News – November/December 2013 – Throwback Edition

July 20, 2016

BioPharma Patents Quick Tips & News – July 2016

November 6, 2015

Farewell the ten sequences rule. The new MPEP disposes of the old §803.04 rule.

September 16, 2015

Harness Dickey BioPharma Newsletter

July 31, 2015

Further Guidance from the PTO

March 24, 2015

Going All In

January 22, 2015

The USPTO Giveth and Taketh Away: New PTA Rules Following Novartis v. Lee

December 17, 2014

Myriad Disappointments for Biotech, but Hope Remains

December 16, 2014

The December Sequel to the USPTO’s March Guidance

December 8, 2014

BPCIA

December 4, 2014

District Court Obviousness Determination Not Up to Par®

March 31, 2014

Written description for functional limitations in view of Alcon Research Ltd. v. Barr Labs.

Posts navigation

1 2 Load more posts

Stay current

  • Subscribe to our Blogs
  • Twitter
  • Facebook
  • LinkedIn
    • Privacy Statement
    • Legal Notice

  • © 2017 Harness, Dickey & Pierce, P.L.C. All rights reserved.